Clinical Trial Update: ELISA in Relapsed/Refractory MM [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of ELISA in relapsed/refractory multiple myeloma, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Relapsed Refractory Multiple Myeloma (RRMM), Relapsed Refractory Multiple Myeloma | Phase 2 | Status: RECRUITING